Discover 1,558 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,558
Active & Responsive
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Inwood NY, The Bronx NY, Princeton NJ, Toms River NJ,
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for
Coronavirus Disease (COVID-19)
Location: Newark NJ, New York NY, Teaneck NJ, The Bronx NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06667700
Phase3, Recruiting
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Jersey City NJ, Horsham PA, Philadelphia PA,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Location: New York NY, Hackensack NJ, Alexandria VA, Toronto,
Sponsor: PROCEPT BioRobotics
Sex: Male
Age: 45+
Code: NCT06651632
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, The Bronx NY, New Brunswick NJ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
for
NSCLC, NSCLC Stage IV, NSCLC Stage IIIB,
Location: New York NY, Morristown NJ, Boston MA, Fairfax VA,
Sponsor: Mythic Therapeutics
Sex: All
Age: 18+
Code: NCT05652868
Phase1, Recruiting
Active & Responsive
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
for
Lymphoma, Non-Hodgkin, Hodgkin Disease
Location: New York NY, Hackensack NJ, Valhalla NY, New Haven CT,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 0 - 30
Code: NCT05255601
Phase1, Phase2, Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT